Heroin dependence duration influences the metabolic parameters: Mechanisms and consequences of impaired insulin sensitivity in hepatitis C virus seronegative heroin dependents

Journal of Addiction Medicine

Volumn 6, Issue 4, 2012, Pages 304-310

  Pereska, Zanina ^a,f   Bozinovska, Cvetanka ^a   Dimitrovski, Cedo ^b   Cakalarovski, Koco ^c   Chibishev, Andon ^a   Zdravkovska, Milka ^d   Babulovska, Aleksandra ^a   Janicevic, Daniela ^e  

^a University Clinic of Psychiatry   (Macedonia)

^b Clinic of Endocrinology and Metabolic Disorders   (Macedonia)

^c University Clinic of Nephrology   (Macedonia)

^d GOCE DELCEV UNIVERSITY   (Macedonia)

^e Vodnjanska Str 17   (Macedonia)

^f SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Dependence duration; Heroin; HOMA B ; HOMA IR

Indexed keywords

ASPARTATE AMINOTRANSFERASE; DIAMORPHINE; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B LYMPHOCYTE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE METABOLISM; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

ADULT; BODY MASS INDEX; BUPRENORPHINE; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HEROIN; HEROIN DEPENDENCE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MACEDONIA (REPUBLIC); MALE; METABOLIC SYNDROME X; MODELS, THEORETICAL; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84871191300     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31826bd76c     Document Type: Article

References (56)

1. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275:9047-9054.
2. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366(9491):1059-1062.
3. Bonora E, Targher G, Alberichie M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
4. Brambilla F, Guerrini A, Guastalla A, Beretta P, Maio DD. Glucose-insulin metabolism in heroin addicts. Neuropsychobiologia 1976;2(5-6):341-349.
5. Brenneisen R, Hasler F. GC/MS determination of pyrolysis products from diacetilmorphine and adulterans of street heroin examples. J Forensic Sci 2002;47(4):885-888.
6. Brinkman GL, Coates EO, Jr. The effect of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis 1964;87:684-693.
7. Ceriello A, Giugliano D, Passarello N, et al. Impaired glucose metabolism in heroin and methadone users. Horm Metb Res 1987;19(9) 430-433.
8. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev. 1995;16(2):117-142.
9. Chen L, Cao ZL, Han F, Gao ZC, He QY. Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance. Chin Med J 2010;123(4):463-470.
10. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469.
11. Cortez-Pinto H. Concluding remarks: metabolic syndrome, liver and HCV. Aliment Pharmacol Ther. 2005;22(2):83-85.
12. Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract 2009;15(3):227-234.
13. Geroldi C, Frisoni GB, Paolisso G, et al. Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005;62(7):1067-1072.
14. Gerra G, Zaimovic A, Moi G, et al. Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlates. Prog Neuropsy-chopharmacol Biol Psychiatry, 2004;28(1):129-139.
15. Giugliano D, Quatraro A, Consoli G, et al. Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. Acta Diabetol Lat. 1987;24(3):205-212.
16. Gómez-Lechón MJ, Ponsoda X, Jover R, Fabra R, Trullenque R, Castell JV. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes. Mol Toxicol 1987-1988;1(4):453-463.
17. Green IC, Perrin D, Pedley KC, Leslie RD, Pyke DA. Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 1980;19(2):158-161.
18. Hashiguchi Y, Molina PE, Abumrad N. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide. Brain Res Bull 1995;38(4):325-329.
19. Holán V, Zajícová A, Krulova M, Blahoutová V, Wilczek H. Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice. Clin Exp Immunol. 2003;132(1):40-45.
20. Houghtling RA, Bayer BM. Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland. J Pharmacol Exp Ther. 2002;300(1):213-219.
21. Housova J, Wilczek H, Haluzik MM, Kremen J, Krízová J, Haluzík M. Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res 2005;54:73-78.
22. Howard AA, Floris-Moore M, Arnsten JH, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 2005;40(10):1492-1499.
23. Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS. Abnormal glucose metabolism among older men with or at-risk for HIV. HIV Med 2006;7(6):389-396.
24. Howard AA, Klein RS, Schoenbaum EE. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 2003;36(10):1318-1323.
25. Ipp E, Dobbs R, Unger RH. Morphine and β-endorphin influence the secretion of the endocrine pancreas. Nature 1978;276:190-191.
26. Johnson KH, Bazargan M, Cherpitel CJ. Alcohol, tobacco, and drug use and the onset of type 2 diabetes among inner-city minority patients. J Am Board Fa m P ra c t 2001;14(6):430-436.
27. Kalyoncu A, Mirsal H, Pektasx OË, Tan D, Beyazyürek M. Heroin-dependent patients attempting and not attempting suicide: a comparison. Acta Neu-ropsychiatr 2007;19:297-303.
28. Kang ES, Yun YS, Park SW, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism 2005;54(2):206-211.
29. Kapasi AA, Gibbons N, Mattana J, Singhal PC. Morphine stimulates mesan-gial cell TNF-α and nitrite production. Inflammation 2000;24(5):463-476.
30. Khawaja XZ, Green IC. Dual action of β-endorphin on insulin release in genetically obese and lean mice. Peptides 1991;12(2):227-233.
31. Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001;24:588-597.
32. Lesley LM, Kacker S, Bickerton AC, Robinson LE, Graham TE. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high et low glycemic index meals in healthy men. Am J Clin Nutr 2008;87:1254-1261.
33. Li Y, Eitan S, Wu J, et al. Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 2003;17:6255-6266.
34. Lin X, Wang YJ, Li Q, et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J 2009;276(7):2022-2036.
35. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol2009;106(5):1538-1544.
36. Madera-Salcedo K, Cruz SL, Gonzalez-Espinosa C. Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-α release. J Neuroimmunol 2010;32(8):599-620.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
38. McDonald T, Hoffman WE, Berkowitz R, Cunningham F, Cooke B. Heart rate variability and plasma catecholamines in patients during opioid detoxification. J Neurosurg Anesthesiol 1999;11(3):195-199.
39. Miyatake M, Rubinstein TJ, McLennan GP, Belcheva MM, Coscia CJ. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and β-arrestin 2-dependent pathways. J Neurochem 2009;110(2):662-674.
40. Molina PE, Hashiguchi Y, Ajmal M, Mazza M, Abumrad NN. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6- glucuronide. Brain Res 1994;664(1-2):126-132.
41. Passariello N, Giugliano D, Ceriello A, Chiariello A, Sgambato S, D'Onofrio F. Impaired insulin response to glucose but not toargininein heroin addicts. J Endocrinol Invest 1986;9:353-357.
42. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexesof abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73(7):460-468.
43. Reed JL, Ghodse AH. Oral glucose tolerance and hormonal response in heroin-dependent males. BMJ 1973;2:582-585.
44. Rose AJ, Hermos JA, Frayne SM, Pogach LM, Berlowitz DR, Miller DR. Does opioid therapy affect quality of care for diabetes mellitus? Am J Manag Care 2009;15(4):217-224.
45. Rudidi A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3L-1 adipocites. Diabetes 1998;47:1562-1569.
46. Sabio G, Das M, Mora A. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008;322:1539-1543.
47. Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep 1993;108(4):492-500.
48. Stoermera R, Dreweb J, Dursteler-Mac Farlandc KM, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry 2003;54(8):854-861.
49. Suarez-Pinzon WL, Lakey JR, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human Islet β-cells from pancreatic duct cells and an increase in functional β-cell mass. J Clin Endocrinol Metab 2005;90(6):3401-3409.
50. Tanti JF, Grémeaux T, Rochet N, Van Obberghen E, Le Marchand-Brustel Y. Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity. Biochem J 1987;245(1):19-26.
51. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense statusofinsulin-producing cells. Diabetes 1997;46:1733-1742.
52. Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979;28(11):1086-1096.
53. Verspohl EJ, Berger U, Ammon HP. The significance of mu-and delta-receptors in rat pancreatic islets for the opioid-mediated insulin release. Biochim Biophys Acta 1986;888(2):217-224.
54. Zandomeneghi R, Luciani A, Massari M, Montanari P, Pavesi C. Effects of heroin addiction on the response of glucose, C-peptide and insulin to a standard meal. Clin Sci (Lond) 1988;74(3):283-288.
55. Zeman M, Jirak R, Jachymova M, Vecka M, Tvrzicka E, Zak A. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinol Lett 2009;30(3):387-395.
56. Zhou JF, Yan XF, Ruan ZR, et al. Heroin abuse and nitric oxide, oxidation, peroxidation, lipoperoxidation. Biomed Environ Sci 2000;13:131-139.